DURECT Corporation

États‑Unis d’Amérique


Commandez votre montre hebdomadaire DURECT Corporation
Quantité totale PI 121
Quantité totale incluant filiales 121 (+ 0 pour les filiales)
Rang # Quantité totale PI 11 000
Note d'activité PI 2,8/5.0    74
Rang # Activité PI 9 397
Symbole boursier
ISIN US2666051048
Capitalisation 24.10M  (USD)
Industrie Drug Manufacturers - Specialty & Generic
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

33 11
15 7
44 3
8
 
Dernier brevet 2025 - Compositions comprising 5-choles...
Premier brevet 1990 - Osmotically driven syringe with ...
Dernière marque 2022 - DURECT
Première marque 1976 - ALZET

Filiales

2 subsidiaries with IP (0 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable...
2024 Invention Treatment of alcohol-associated hepatitis. Methods of treating alcohol-associated hepatitis (AH) ...
2023 Invention 25-hydroxy-cholest-5-en-3-sulfate choline, formulations thereof and methods for preparing, and me...
Invention Sustained release drug delivery systems with reduced impurities and related methods. The present...
Invention Uses of oxygenated cholesterol sulfates (ocs). Methods of preventing and/or treating ischemia, o...
Invention Depot formulations. Disclosed are formulations and related methods that comprise a non-polymeric...
2022 Invention Salts including crystalline salts of 25-hydroxy-cholest-5-en-3-sulfate and methods for preparing ...
Invention Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involvin...
P/S Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders,...
P/S Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders...
Invention 25-hydroxy-cholest-5-en-3-sulfate choline and methods for preparing, and uses of, same. 25HC3S c...
Invention 25-hydroxy-cholest-5-en-3-sulfate choline and methods for preparing, and uses of, same. 25HC3S ch...
Invention Sustained release drug delivery systems and related methods. The present disclosure provides for...
P/S Miniature fluid dispensers for experimental use in laboratory animals, not for medical purposes; ...
Invention Compositions and methods involving polymer, solvent and high viscosity liquid carrier material. ...
Invention Sustained release drug delivery systems with reduced impurities and related methods. The present ...
Invention Sustained release drug delivery systems and related methods. The present disclosure provides for ...
2021 Invention Compositions comprising oxygenated cholesterol sulfate and at least one of polyalkylene glycol, c...
Invention Crystalline sodium cholesteryl sulfate. Crystalline forms of crystalline sodium cholesteryl sulf...
Invention Crystalline thiocholesterol. Crystalline forms of thiocholesterol are disclosed herein. Such for...
Invention Crystalline sodium cholesteryl sulfonate. Crystalline and non-crystalline forms of crystalline s...
Invention Crystalline sodium cholesteryl sulfonate. Crystalline and non-crystalline forms of crystalline so...
Invention Crystalline sodium cholesteryl sulfate. Crystalline forms of crystalline sodium cholesteryl sulfa...
Invention Crystalline thiocholesterol. Crystalline forms of thiocholesterol are disclosed herein. Such form...
Invention Peroxide removal from drug delivery vehicle. The present invention is related to methods for low...
Invention Use of oxygenated cholesterol sulfates for treating inflammatory conditions. Aspects of the pres...
Invention Use of oxygenated cholesterol sulfates for treating autoimmune conditions. Aspects of the presen...
Invention Use of oxygenated cholesterol sulfates for treating at least one of insulin resistance, diabetes,...
Invention Use of oxygenated cholesterol sulfates for cancers and non-cancerous transformations related to e...
Invention Use of oxygenated cholesterol sulfates for treating neurological conditions, neurodegenerative di...
Invention Use of oxygenated cholesterol sulfates for treating autoimmune conditions. Aspects of the present...
Invention Use of oxygenated cholesterol sulfates for treating inflammatory conditions. Aspects of the prese...
Invention Treatment of non-alcoholic steatohepatitis (nash). Methods of treating non-alcoholic steatohepat...
Invention Treatment of non-alcoholic steatohepatitis (nash). Methods of treating non-alcoholic steatohepati...
Invention Biodegradable drug delivery composition. The present disclosure provides a biodegradable drug de...
Invention Treatment of infectious diseases. Methods of treating infectious diseases are provided. For inst...
Invention Treatment of infectious diseases. Methods of treating infectious diseases are provided. For insta...
2020 Invention Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for prepa...
Invention Radiation-sterilized biodegradable drug delivery compositions. The present disclosure is directe...
Invention Treatment of alcoholic hepatitis. Methods of treating alcoholic hepatitis (AH) are provided. For...
Invention Long-acting formulations and vehicles. The present disclosure provides long-acting formulations ...
Invention Long-acting formulations of tenofovir alafenamide. The present disclosure provides long-acting f...
P/S Pharmaceutical preparations.
P/S pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders,...
2013 P/S Surgical, medical, dental and veterinary materials, namely, pharmaceuticals and preparations for ...
P/S Surgical, medical, dental and veterinary materials, namely, pharmaceuticals and preparations for...
2011 P/S Pharmaceutical transdermal or topical drug delivery formulations, namely, drug delivery agents co...
2010 P/S Pharmaceutical drug delivery systems, namely, drug delivery formulations used with various medica...
2009 P/S Research and development of pharmaceutical preparations and medical devices; research and develop...
P/S Surgical or medical pharmaceutical preparations, namely, injectable and implantable drug delivery...
2005 P/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ...
2000 P/S [ Surgical, medical, dental, and veterinary instruments and apparatus, namely, speculum; products...
P/S Miniature fluid dispensers for experimental use in laboratory animals; [and in vitro] implantable...
P/S Miniature fluid dispensers for experimental use in laboratory animals and in vitro; implantable a...
P/S Surgical, medical, dental and veterinary instruments and apparatus; miniature fluid dispensers fo...
1999 P/S Pharmaceuticals and drug delivery products; but not including contraceptive preparations and subs...
1976 P/S Miniature fluid dispensers for experimental use in laboratory animals or in vitro. Miniature flui...